These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3624052)
21. A review of hypoxic cell radiosensitization. Dische S Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):147-52. PubMed ID: 1993624 [TBL] [Abstract][Full Text] [Related]
22. The emerging biology of modern radiation oncology. Goffman TE; Raubitschek A; Mitchell JB; Glatstein E Cancer Res; 1990 Dec; 50(24):7735-44. PubMed ID: 2253216 [No Abstract] [Full Text] [Related]
23. Comment on "survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II Study". Phillips TL Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1281-2. PubMed ID: 8985057 [No Abstract] [Full Text] [Related]
24. The use of radioimmunotherapy in combination with bioreductive agents. Langmuir VK Recent Results Cancer Res; 1996; 141():137-43. PubMed ID: 8722424 [No Abstract] [Full Text] [Related]
25. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors]. Kiseleva ES; Dar'ialova SL Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719 [No Abstract] [Full Text] [Related]
26. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases]. Lokshina AM; Pelevina II Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617 [No Abstract] [Full Text] [Related]
27. Radiosensitizers: a conference preview. Adams GE Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183 [No Abstract] [Full Text] [Related]
28. Facing fearful odds--a conference summary. Hall EJ Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1023-6. PubMed ID: 3744925 [No Abstract] [Full Text] [Related]
34. Radiation therapy of cancer. Modification of response. Pa Med; 1972 Feb; 75(2):91. PubMed ID: 5042618 [No Abstract] [Full Text] [Related]
35. On the path to seeking novel radiosensitizers. Katz D; Ito E; Liu FF Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):988-96. PubMed ID: 19251086 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in combined modality therapy. Mierzwa ML; Nyati MK; Morgan MA; Lawrence TS Oncologist; 2010; 15(4):372-81. PubMed ID: 20413642 [TBL] [Abstract][Full Text] [Related]
37. The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers. Salehifar E; Hosseinimehr SJ Drug Discov Today; 2016 Apr; 21(4):654-62. PubMed ID: 26955911 [TBL] [Abstract][Full Text] [Related]
38. The role of UFT in combined-modality therapy. Blanke CD; Teng M; Choy H Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826 [TBL] [Abstract][Full Text] [Related]
39. [Chemoradiotherapy: history and state of the art]. Cosset JM Cancer Radiother; 1998 Dec; 2(6):653-6. PubMed ID: 9922767 [TBL] [Abstract][Full Text] [Related]